help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 73, No. 6 1241-1247
doi:10.1210/jcem-73-6-1241
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KLETTER, G. B.
Right arrow Articles by KELCH, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KLETTER, G. B.
Right arrow Articles by KELCH, R. P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*NALOXONE
*SODIUM CHLORIDE
*TESTOSTERONE

Naloxone Does not Reverse the Suppressive Effects of Testosterone Infusion on Luteinizing Hormone Secretion in Pubertal Boys*

GAD B. KLETTER, CAROL M. FOSTER, MORTON B. BROWN, VASANTHA PADMANABHAN, INESE Z. BEITINS, JOHN C. MARSHALL and ROBERT P. KELCH

Departments of Pediatrics University of Michigan Ann Arbor, Michigan 48109-0718
Biostatistics University of Michigan Ann Arbor, Michigan 48109-0718
Internal Medicine University of Michigan, Ann Arbor, Michigan 48109-0718

Address all correspondence and requests for reprints to: Gad B. Kletter, M.D., University of Michigan, Division of Pediatric Endocrinology, MPB D3252, Box 0718, Ann Arbor, Michigan 48109-0718.

In this study we wished to test whether, and if so when, the suppressive effects of testosterone on LH and, by inference, GnRH secretion are mediated via endogenous opioid pathways during male pubertal maturation. As a preliminary study, we evaluated the acute effects of a 24-h infusion of testosterone (T) in eight pubertal boys with constitutional delay of growth in order to determine the optimal time for administration of naloxone. Eight additional pubertal boys received a saline infusion, followed 1 week later by a similar T infusion starting at 1000 h and lasting for 33 h. After 2 h of infusion (both saline and T), four iv boluses of saline were given hourly, and after 26 h of infusion, four hourly iv boluses of naloxone were given. Blood was obtained every 15 min for LH and every 30 min for T measurements. T infusion increased the mean T concentration by 3.8–fold (P < 0.001). Mean LH and LH pulse frequency were suppressed (P < 0.01), and the sleep-associated increase in LH secretion was abolished. Naloxone administration during the infusion of T did not reverse the suppression of LH secretion. Compared to the saline control period, mean LH was significantly lower during T infusion during the time naloxone boluses were given (4.5 ± 0.9 vs. 5.9 ± 1.1 IU/L, T infusion and naloxone boluses vs. saline respectively, P < 0.01). Although the suppression of LH pulse frequency remained significantly lower than that during the saline control period (0.23 ± 0.04 pulses/boy.h during T infusion and saline boluses; 0.33 ± 0.04 pulses/boy.h during T infusion plus naloxone boluses; 0.44 ± 0.06 pulses/ boy.h during saline infusion and saline boluses). Naloxone increased mean LH and LH pulse frequency only in the four older, more mature boys during the infusion of saline. Pituitary responsiveness to exogenous GnRH was not altered by infusion of T.

We conclude that acute administration of T suppresses LH secretion and, by inference, GnRH secretion at all stages of pubertal maturation in boys. These negative feedback effects, however, cannot be reversed by coadministration of naloxone, even in mid-to late pubertal boys who respond to naloxone with increased pulsatile secretion of LH. These studies suggest that during pubertal maturation in boys, endogenous opioid pathways do not play a major role in the regulation of the negative feedback effects of T.

* This work was supported by NIH Grant HD-16000 and Clinical Research Center Grant MOl-RR-00042.

Received April 1, 1991.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. P. Cemeroglu, G. B. Kletter, W. Guo, M. B. Brown, R. P. Kelch, J. C. Marshall, V. Padmanabhan, and C. M. Foster
In Pubertal Girls, Naloxone Fails to Reverse the Suppression of Luteinizing Hormone Secretion by Estradiol
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3501 - 3506.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G.B. Kletter, V. Padmanabhan, I.Z. Beitins, J.C. Marshall, R.P. Kelch, and C.M. Foster
Acute Effects of Estradiol Infusion and Naloxone on Luteinizing Hormone Secretion in Pubertal Boys
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4010 - 4014.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society